Bayer another US glyphosate trial delayed until further notice Medical Dialogues Bureau7 Oct 2019 9:00 AM IST"With the change in the trial schedule and no trial dates set through the rest of the year, the appeals of the three completed trials will be a...
ZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademark Farhat Nasim6 Oct 2019 11:10 AM ISTNew Delhi: In a relief to the pharmaceutical giant in a trademark matter, the Delhi High Court has recently restrained the manufacture or sale of...
Lupin gets USFDA nod for generic equivalet of Dilantin Medical Dialogues Bureau6 Oct 2019 10:00 AM ISTExtended Phenytoin Sodium Capsules USP,100 mg (RLD: Dilantin) had annual sales of approximately USD 105 million in the U.S. (IQVIA MAT June 2019),...
Novartis, Microsoft collaborate to transform medicine with AI Medical Dialogues Bureau6 Oct 2019 9:45 AM ISTThe new lab aims to bolster Novartis AI capabilities from research through commercialization and help accelerate the discovery and development of...
Janssen Pharma bags breakthrough designation for niraparib in prostate cancer Farhat Nasim6 Oct 2019 9:25 AM ISTNew Delhi: The Janssen Pharmaceutical Companies of Johnson & Johnson (JnJ) announced recently that the U.S. Food and Drug Administration (FDA) has...
Q BioMed acquires USFDA approved cancer pain drug Strontium-89 Chloride Medical Dialogues Bureau6 Oct 2019 9:15 AM ISTStrontium-89 is an important therapeutic option for the treatment of metastatic bone cancer pain. The drug has a long history of providing...
Lupin Mandideep facility red-flagged by USFDA for CGMP violations Farhat Nasim5 Oct 2019 12:18 PM ISTNEW DELHI: The US health regulator has red-flagged pharma firm Lupin for significant violations of the current good manufacturing practice regulations...
SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA Farhat Nasim5 Oct 2019 12:00 PM ISTOrphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of patients with neonatal...
Lupin unveils generic version of CellCept in US Farhat Nasim5 Oct 2019 9:30 AM ISTLupin Ltd's Mycophenolate Mofetil Capsules USP, 250 mg, is the generic version of Roche’s CellCept. Mumbai: Pharma major Lupin Limited (Lupin)...
JnJ submits New Drug Application to USFDA for Spravato Medical Dialogues Bureau5 Oct 2019 9:00 AM ISTNew Delhi: The Janssen Pharmaceutical Companies of Johnson & Johnson(JnJ) recently announced the submission of a supplemental New Drug Application...
AstraZeneca auto-injector pen Fasenra for asthma treatment gets USFDA green light Farhat Nasim4 Oct 2019 1:42 PM ISTFasenra self-administration and the Fasenra Pen are already approved in the European Union and the drug is part of AstraZeneca’s newer class of...
Lupin ropes in Jon Stelzmiller to head US specialty business Medical Dialogues Bureau26 Sept 2019 4:54 PM ISTNew Delhi: Homegrown pharma major Lupin on Wednesday announced appointment of Jon Stelzmiller as the President of its US specialty business....
